| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |